1. Clinical and clinicopathological parameters of gastric cancer with peritoneal metastasis.
| Characteristics | Total patients
[n (%)] |
HIPEC-chemotherapy
(N=249) [n (%)] |
Chemotherapy alone
(N=249) [n (%)] |
P |
| BMI, body mass index; ECOG PS, Eastern Cooperative Oncology Group performance status; HIPEC, hyperthermic intraperitoneal chemotherapy. | ||||
| Sex | ||||
| Female | 201 (40.4) | 105 (42.2) | 96 (38.6) | |
| Male | 297 (59.6) | 144 (57.8) | 153 (61.4) | 0.411 |
Age (
) (year)
|
55.3±12.5 | 54.6±11.8 | 56.0±13.1 | 0.230 |
BMI (
) (kg/m2)
|
21.4±3.6 | 21.5±3.4 | 21.4±3.9 | 0.742 |
| ECOG PS | ||||
| 0 or 1 | 450 (90.4) | 224 (90.0) | 226 (90.8) | |
| 2 or 3 | 48 (9.6) | 25 (10.0) | 23 (9.2) | 0.761 |
| Histology | ||||
| Differentiated | 75 (15.1) | 41 (16.5) | 34 (13.7) | |
| Undifferentiated | 423 (84.9) | 208 (83.5) | 215 (86.3) | 0.380 |
| Ascites fluid amount | ||||
| None | 335 (67.3) | 161 (64.7) | 174 (69.9) | |
| Little | 83 (16.7) | 43 (17.3) | 40 (16.1) | |
| Moderate/Large | 80 (16.0) | 45 (18.0) | 35 (14.0) | 0.394 |
| P stage | ||||
| P1 | 156 (31.3) | 81 (32.5) | 75 (30.1) | |
| P2 | 139 (27.9) | 70 (28.1) | 69 (27.7) | |
| P3 | 197 (39.6) | 96 (38.6) | 101 (40.6) | |
| Unknown | 6 (1.2) | 2 (0.8) | 4 (1.6) | 0.794 |
Time to first flatus (
) (d)
|
3.6±2.3 | 4.6±2.4 | 2.7±1.8 | <0.001 |
Hospital stay (
) (d)
|
12.8±7.0 | 14.2±5.8 | 11.4±7.7 | <0.001 |